Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Overview

FRA:EWL - US28176E1082 - Common Stock

70.2 EUR
+0.07 (+0.1%)
Last: 9/2/2025, 7:00:00 PM

EWL.DE Key Statistics, Chart & Performance

Key Statistics
52 Week High73.62
52 Week Low58.18
Market Cap41.21B
Shares587.10M
Float579.94M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.21
PE31.76
Fwd PE28.47
Earnings (Next)10-22 2025-10-22/amc
IPO03-27 2000-03-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


EWL.DE short term performance overview.The bars show the price performance of EWL.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8

EWL.DE long term performance overview.The bars show the price performance of EWL.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10

The current stock price of EWL.DE is 70.2 EUR. In the past month the price increased by 2.66%. In the past year, price increased by 17.73%.

EDWARDS LIFESCIENCES CORP / EWL Daily stock chart

EWL.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 26.62 195.07B
IUI1.DE INTUITIVE SURGICAL INC 58 143.66B
BSX.DE BOSTON SCIENTIFIC CORP 37.7 135.73B
1BSX.MI BOSTON SCIENTIFIC CORP 37.12 133.45B
2M6.DE MEDTRONIC PLC 16.9 102.96B
1SHL.MI SIEMENS HEALTHINEERS AG 19.87 53.35B
SHL.DE SIEMENS HEALTHINEERS AG 19.61 52.63B
BOX.DE BECTON DICKINSON AND CO 13.28 46.63B
DC4.DE DEXCOM INC 43.84 25.10B
PHIA.AS KONINKLIJKE PHILIPS NV 16.13 22.37B
PHI1.DE KONINKLIJKE PHILIPS NV 16.1 22.32B
QS51.DE STRAUMANN HOLDING AG-REG 34.96 15.72B

About EWL.DE

Company Profile

EWL logo image Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Company Info

EDWARDS LIFESCIENCES CORP

One Edwards Way

Irvine CALIFORNIA US

Employees: 15800

EWL Company Website

EWL Investor Relations

Phone: 19492502500

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

What is the stock price of EDWARDS LIFESCIENCES CORP today?

The current stock price of EWL.DE is 70.2 EUR. The price increased by 0.1% in the last trading session.


What is the ticker symbol for EDWARDS LIFESCIENCES CORP stock?

The exchange symbol of EDWARDS LIFESCIENCES CORP is EWL and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is EWL.DE stock listed?

EWL.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for EDWARDS LIFESCIENCES CORP stock?

43 analysts have analysed EWL.DE and the average price target is 76.26 EUR. This implies a price increase of 8.63% is expected in the next year compared to the current price of 70.2. Check the EDWARDS LIFESCIENCES CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EDWARDS LIFESCIENCES CORP worth?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a market capitalization of 41.21B EUR. This makes EWL.DE a Large Cap stock.


How many employees does EDWARDS LIFESCIENCES CORP have?

EDWARDS LIFESCIENCES CORP (EWL.DE) currently has 15800 employees.


What are the support and resistance levels for EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a support level at 68.23 and a resistance level at 70.21. Check the full technical report for a detailed analysis of EWL.DE support and resistance levels.


Is EDWARDS LIFESCIENCES CORP (EWL.DE) expected to grow?

The Revenue of EDWARDS LIFESCIENCES CORP (EWL.DE) is expected to grow by 3.67% in the next year. Check the estimates tab for more information on the EWL.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EDWARDS LIFESCIENCES CORP (EWL.DE) stock pay dividends?

EWL.DE does not pay a dividend.


When does EDWARDS LIFESCIENCES CORP (EWL.DE) report earnings?

EDWARDS LIFESCIENCES CORP (EWL.DE) will report earnings on 2025-10-22, after the market close.


What is the Price/Earnings (PE) ratio of EDWARDS LIFESCIENCES CORP (EWL.DE)?

The PE ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 31.76. This is based on the reported non-GAAP earnings per share of 2.21 and the current share price of 70.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EWL.DE.


EWL.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to EWL.DE. When comparing the yearly performance of all stocks, EWL.DE is one of the better performing stocks in the market, outperforming 72.59% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

EWL.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE. EWL.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EWL.DE Financial Highlights

Over the last trailing twelve months EWL.DE reported a non-GAAP Earnings per Share(EPS) of 2.21. The EPS decreased by -0.77% compared to the year before.


Industry RankSector Rank
PM (TTM) 72.96%
ROA 30.75%
ROE 39.33%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%-4.29%
Sales Q2Q%-6.13%
EPS 1Y (TTM)-0.77%
Revenue 1Y (TTM)-1.09%

EWL.DE Forecast & Estimates

43 analysts have analysed EWL.DE and the average price target is 76.26 EUR. This implies a price increase of 8.63% is expected in the next year compared to the current price of 70.2.

For the next year, analysts expect an EPS growth of -1.88% and a revenue growth 3.67% for EWL.DE


Analysts
Analysts76.28
Price Target76.26 (8.63%)
EPS Next Y-1.88%
Revenue Next Year3.67%

EWL.DE Ownership

Ownership
Inst Owners88.93%
Ins Owners0.16%
Short Float %N/A
Short RatioN/A